National Cancer Institute; Notice of Partially Closed Meeting

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 201 (Tuesday, October 20, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 201 (Tuesday, October 20, 2026)]
[Notices]
[Pages 66339-66340]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-21401]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Partially Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board.
    The meeting will be partially open to the public as indicated 
below, with attendance limited to space available. Individuals who plan 
to attend as well as those who need special assistance, such as sign 
language interpretation or other reasonable accommodation, must notify 
the Contact Person listed below in advance of the meeting. The open 
session will be videocast and can be accessed from the NIH Videocasting 
and Podcasting website (<a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>).
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The intramural programs and projects and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the intramural programs and 
projects,

[[Page 66340]]

the disclosure of which would constitute a clearly unwarranted invasion 
of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Date: December 2, 2026.
    Open: 9:30 a.m. to 11:40 a.m.
    Agenda: National Cancer Advisory Board Subcommittee Meetings.
    Open: 12:00 p.m. to 4:00 p.m.
    Agenda: Director's and program reports, presentations, and Board 
business.
    Closed: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate the intramural program, site 
visit outcomes, and discussions of confidential personnel issues.
    Address: National Institutes of Health, National Cancer 
Institute--Shady Grove, 9609 Medical Center Drive, Rockville, MD 
20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Shamala K. Srinivas, Ph.D., Acting Director, 
Division of Extramural Activities, National Cancer Institute--Shady 
Grove, National Institutes of Health, 9609 Medical Center Drive, 7th 
Floor, Room 7W444, Bethesda, MD 20892, 240-276-6340, 
<a href="/cdn-cgi/l/email-protection#cbb8a3aaa6aaa7aa8ba6aaa2a7e5a5a2a3e5aca4bd"><span class="__cf_email__" data-cfemail="8efde6efe3efe2efcee3efe7e2a0e0e7e6a0e9e1f8">[email&#160;protected]</span></a>.

    Registration is not required to attend the open portion of this 
meeting.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Persons listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's Advisory 
Board's web page on <a href="https://www.cancer.gov/about-nci/advisory-boards/ncab/meetings/2026#december-1-2-2026-173rd-regular-meeting">https://www.cancer.gov/about-nci/advisory-boards/ncab/meetings/2026#december-1-2-2026-173rd-regular-meeting</a>, 
where an agenda and any additional information for the meeting will 
be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 15, 2026.
Kuleni D. Onnen,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-21401 Filed 10-19-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>